Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial

Journal article

Peer reviewed

JAMA : the journal of the American Medical Association, Vol.285(5), p.512

07/02/2001

Abstract

Breast cancer

Drug therapy

Evaluation

Tamoxifen

1 Record Views

Title: Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial
Creators - without role: J. M Nabholtz
Publication Details: JAMA : the journal of the American Medical Association, Vol.285(5), p.512
Publisher: American Medical Association
Identifiers: 9952710708331
Academic Unit: King Saud University
Language: English
Resource Type: Journal article